Repeated remote ischaemic preconditioning can prevent acute mountain sickness after rapid ascent to a high altitude.

This study demonstrated that a four-week RIPC intervention but not a one-week regimen reduced AMS incidence and severity; however, a placebo effect might have contributed to these results.